Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant

Susan Prockop; Ekaterina Doubrovina; Aisha N Hasan; Parastoo B Dahi; Sergio Giralt; Guenther Koehne; Nancy A. Kernan; Esperanza B Papadopoulos; Rachel Lehrman; Irene Rodriguez-Sanchez; Richard J. O'Reilly

Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant

Susan Prockop, Ekaterina Doubrovina, Aisha N Hasan, Parastoo B Dahi, Sergio Giralt, Guenther Koehne, Nancy A. Kernan, Esperanza B Papadopoulos, Rachel Lehrman, Irene Rodriguez-Sanchez, Richard J. O'Reilly

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Dec 2 2016
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Virology
Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

@conference{401ecd6afb9043d08a30ab7116bc013f,

title = "Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant",

author = "Susan Prockop and Ekaterina Doubrovina and Hasan, \{Aisha N\} and Dahi, \{Parastoo B\} and Sergio Giralt and Guenther Koehne and Kernan, \{Nancy A.\} and Papadopoulos, \{Esperanza B\} and Rachel Lehrman and Irene Rodriguez-Sanchez and O'Reilly, \{Richard J.\}",

note = "Adoptive immunotherapy with transplant donor derived virus specific T cells is an effective strategy for the treatment of CMV viremia and disease arising after an allogeneic hematopoietic stem cell (HSCT).; Blood ; Conference date: 01-01-2020",

year = "2016",

month = dec,

day = "2",

language = "American English",

}

TY - CONF

T1 - Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant

AU - Prockop, Susan

AU - Doubrovina, Ekaterina

AU - Hasan, Aisha N

AU - Dahi, Parastoo B

AU - Giralt, Sergio

AU - Koehne, Guenther

AU - Kernan, Nancy A.

AU - Papadopoulos, Esperanza B

AU - Lehrman, Rachel

AU - Rodriguez-Sanchez, Irene

AU - O'Reilly, Richard J.

N1 - Adoptive immunotherapy with transplant donor derived virus specific T cells is an effective strategy for the treatment of CMV viremia and disease arising after an allogeneic hematopoietic stem cell (HSCT).

PY - 2016/12/2

Y1 - 2016/12/2

UR - http://www.bloodjournal.org/content/128/22/61?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant

Conference

Disciplines

Other files and links

Cite this